Clinical Health Solutions

Spectrum Medical Diagnostics is committed to enhancing patient treatment and diagnosis of substance abuse in Canada.

Our goal is to help Addiction Rehabilitation Centres optimize screening programs to achieve better health outcomes.

We are committed to providing comprehensive solutions that offer accurate, reliable results.

With over 20 years of expertise in this industry, you can count on us to provide insight into the latest trends and offer solutions that best suit your screening requirements.

Featured Solutions

At Spectrum Medical Diagnostics, offer you full customization and control of the products you purchase to ensure that your screening program fits your needs.

SpecCheck, Canada's Preferred Multi-Panel Test Cup

Our Multi-Panel Test Cup.

  • Quick and accurate testing results.
  • Colour-coded tabs for ease of identification.
  • Easy to read results.
  • Can be customized and tailored to your needs.
  • Compliant with Clinical and Occupational Health Standards.

Interested in learning more about the product?

Contact us at (866) 287-2425 or to learn about our customization options.


Impact on Patient Treatment: Mitigating the Risks

Addiction workers may face challenges with screening & diagnoses as Fentanyl could easily be missed.

Being proactive and screening for this synthetic opioid will only enhance your current screening program and help provide optimal patient treatment.

Although a standard drug screen for opiate could potentially detect fentanyl, the chances of this substance being missed on a urine screen are quite high.

The opiate test is not specific to Fentanyl, therefore, the negative impact on patient treatment could be alarmingly severe. With the current opioid crisis Canada is facing, we recommend that Fentanyl and other opioids be added to your existing screening configuration.

Ongoing Screening:

Comprehensive and reliable drug monitoring will ensure that patients are in compliance with treatment programs & receiving the care they require.

Many patients are reluctant to self-disclosing ongoing substance abuse while at a facility, while others might be more upfront if they have a realization their treatment is being jeopardized.

Optimizing your screening program with our value-added solutions will offer your patients enhanced treatment options.

Secondary Screening:

In addition to urine drug testing, many Addiction Rehabilitation Centres are incorporating saliva (oral fluid) drug testing into their outpatient & weekend programs as a secondary screening tool.

Saliva screening can help provide a more thorough and comprehensive analysis as a different matrix.

Some advantages of oral fluid screening include:

  • Determining recent drug use.
  • Shorter detection window of approximately 24 hours.
  • 3-5 days for urine.
  • Non-invasive screening procedure.
  • Detect various substances/metabolites in minutes.
  • Specimen cannot be adulterated.
  • Strong correlation to impairment and consumption.

Comprehensive Training:

Our team specializes in training to ensure your staff can use instruments properly for the most effective results.

Although our screening tools are designed for simple application, proper administration and correct scoring are of the utmost importance in addiction and rehab centres. It is best to have screenings performed by professionally trained staff.

We offer both non-regulated and DOT-regulated programs providing in-depth product training per manufacturer’s guidelines and recommendations.

Your team will receive comprehensive instructions on the correct use of all Spectrum MDX POCT products, including proper collection procedures.

Our Value Proposition:

  • Broad product menu.
  • Screen for a variety of prescription and illicit drugs.
  • Reliable, accurate results.
  • Dedicated team focused on meeting your screening requirements.

Product Enquiry Form

We will help you customize your Clinical Screening Program.

    Canada's Opioid Crisis & Fentanyl

    Fentanyl is a synthetic opiate typically prescribed for cancer patients with severe pain. It has evolved into the next prominent drug on the streets, posing fatal consequences all across North America.

    The risk of overdose is tremendous and can occur within seconds.

    What many people are not aware of is that this drug can be laced with heroin, cocaine or oxycodone, exponentially boosting potency by 50-100 times & making it more toxic than morphine.

    Opioid overdoses have an impact on our society and should be addressed in a national and immediate manner.

    Facts about Fentanyl:

    • Canada has the largest rate of prescriptions for fentanyl.
    • The illicit version of fentanyl is manufactured in China and smuggled into Canada.
    • It is typically laced with heroin, cocaine or oxycodone exponentially boosting potency by 50-100x.
    • Opioid carfentanil (veterinary opioid) is now making its’ way on the streets & is up to 100 times more toxic than fentanyl.
    • It’s sold in pill or powder format and the average user is spending $300+ per day.

    Substances Laced with Fentanyl:

    Several of the popular street drugs have been found to be laced with fentanyl leaving this substance potentially undetected.

    This poses a tremendous concern for addiction rehabilitation as treatment and diagnosis are negatively impacted. According to Health Canada, Fentanyl is often combined with substances such as heroin, cocaine & MDMA to increase potency.

    Fentanyl is easy and inexpensive to manufacture, making it convenient for drug dealers to spike other substances and create counterfeit versions of drugs.

    Unfortunately, recreational drug users are completely unaware they are ingesting the potent painkiller, resulting in overdose and death.

    An additional danger lies in those that are not regular opioid users & inadvertently abusing the drug, as this creates a much greater risk of overdose or death.

    A relatively small amount is considered potent and users are essentially playing Russian roulette with the laced substances.

    Fentanyl Stats in Canada:

    The number of deaths from fentanyl is on the rise each year all across the country.

    Reports show staggering numbers of misuse and overdose deaths occurring at regular intervals.

    British Columbia declared a public health emergency after overdoses killed 200 people in the first three months of 2016.1

    Between 2009 and 2014, there were at least 655 deaths in Canada where fentanyl was determined to be a cause or a contributing cause.

    This represents an average of one fentanyl- implicated death every three days over this time period.1

    Within the last six years, the number of deaths involving fentanyl in Canada’s four largest provinces has increased markedly ranging from almost doubling to an increase of over 20 times.

    Drug users know how to readily obtain the drug and will resort to any means necessary for this elusive high.

    It is widely known that Canada and the U.S are fighting an opioid crisis.

    From overdose and addiction to irregular dissemination, it’s becoming an increasingly large issue both locally and abroad.

    In Ontario, the number of deaths related to prescription opioid overdoses increased five-fold from 1991 to 2004. Recent media reports suggest that the numbers are still climbing. Studies have found that prescription opioids are now the street drug of choice in large Canadian cities.1

    Though the drugs are used for a myriad of reasons, there are arguments against any type of long-term use.

    While these drugs are effective in treating acute pain, and pain near the end of life, the evidence to support long-term use in patients with chronic pain is weak, and for many people, the harms exceed the benefits.

    Prescription opioids are also highly addictive and easily misused.